Bristol’s Sprycel May Increase Hypertension Risk, FDA Says (Drug Safety Developments)

October 12, 2011

Bristol’s Sprycel May Increase Hypertension Risk, FDA Says

Quoted from http://www.bloomberg.com/news/2011-10-11/bristol-s-sprycel-may-increase-hypertension-risk-fda-says.html

Bristol’s Sprycel May Increase Hypertension Risk, FDA Says

By Anna Edney - Oct 11, 2011 10:01 AM ET

Bristol-Myers Squibb Co. (BMY)’s leukemia drug Sprycel may increase the risk of a rare condition that causes high blood pressure in the lungs’ arteries, U.S. regulators said today.

Health-care providers should evaluate patients for signs of underlying cardiopulmonary disease before starting Sprycel, chemically known as dasatinib, and during treatment. If abnormally high blood pressure known as pulmonary arterial hypertension is confirmed, patients should discontinue the medicine, according to the safety announcement from the Food and Drug Administration.

[Article continues at original source]

Posted at 08:58 AM in Sprycel | Permalink

Tags: abnormally high blood pressure, Bristol-Myers Squibb, dasatinib, drug injury, FDA warning, leukemia drug, pulmonary arterial hypertension, side effect, Sprycel

Comments

Patient Advisory

The prescription drugs discussed on this site are approved for use by the the Food and Drug Administration (FDA). Patients should not stop taking any prescription drug without seeking the advice of their medical doctor. This site is not affiliated with any of the drug companies or the FDA.

Free Case Evaluation

We encourage you to submit a Drug Injury Legal Case Evaluation – it is free, confidential, and there is no obligation. Or, if you prefer, call our toll-free number, (800) 426-9535, to speak directly to attorney Tom Lamb about a possible drug injury case. Either way, you will get Mr. Lamb’s impressions — not an intake person, a paralegal, nor some other lawyer — about your case based on his many years of experience handling drug injury lawsuits.

Thank You For Reading

Drug Safety Developments

Regulatory Actions | Medical Studies | Journal Articles

October 12, 2011

Bristol’s Sprycel May Increase Hypertension Risk, FDA Says

Bristol’s Sprycel May Increase Hypertension Risk, FDA Says

Comments

Bristol’s Sprycel May Increase Hypertension Risk, FDA Says

Search Engine

Patient Advisory

Quick Contact Form

Free Case Evaluation

Drug Injury Watch

Thank You For Reading

Drug Safety Developments

Regulatory Actions | Medical Studies | Journal Articles

October 12, 2011

Bristol’s Sprycel May Increase Hypertension Risk, FDA Says

Bristol’s Sprycel May Increase Hypertension Risk, FDA Says

Comments

Bristol’s Sprycel May Increase Hypertension Risk, FDA Says

Search Engine

Patient Advisory

Quick Contact Form

Free Case Evaluation

Drug Injury Watch

Thank You For Reading

Subscribe to Lamb Law Office Newsletter

Subscribe to our Lamb Law Office Newsletter for periodic updates about some of the cases we are working on for clients. We include, also, an information resource you might find helpful in each Newsletter.